MDT

Medtronic
D

MDT

Arincen70/100B

Medtronic P/E ratio

Medtronic's P/E ratio is 24.89: its share price of 101.82 over its earnings per share of 4.09 over the last twelve months.

Today
24.89
Forward P/E, next 12 months
16.41
PEG ratio
1.49
Median, 5 years
26.42
Low, 5 years
19.63
High, 5 years
42.50

P/E ratio = price ÷ EPS (last 12 months) = 101.82 ÷ 4.09 = 24.89

Each day's closing price over the earnings per share of the last four quarters reported by that day (basic EPS, adjusted for splits). The P/E moves with the price every day and with the earnings at each report.

The forward P/E divides the price by the analysts' average EPS estimate for the next twelve months: the fiscal year in progress for the months left in it, the next one for the rest. For past days it uses each year's latest estimate, as the estimates of the time were not recorded (we keep a daily copy from November 2026), so the past line reads the price against the earnings expected by the time each year was reported.

Is Medtronic's P/E high compared with its own history?

Medtronic's P/E of 24.9 is below the middle of its 5-year range (19.6 to 42.5, median 26.4). Analysts do not expect slower growth than in recent years, so it is cheaper than its usual level.

Is the price fair? See the whole check

A P/E is compared with the stock's own last five years, not with other companies. Why the market pays more or less (news, rates, the sector) is not in these figures.

P/E ratio by year and by quarter

Fiscal yearPeriod endingP/E ratioForward P/EMarket capNet income
FY2028 · Estimate24 Apr 202815.92———
FY2027 · Estimate24 Apr 202717.03———
Today24.8916.41130.25B5.27B
FY202624 Apr 202622.0813.94106.80B4.84B
FY202525 Apr 202523.0615.25108.20B4.69B
FY202426 Apr 202428.8014.61105.87B3.68B
FY202328 Apr 202331.9627.63120.95B3.78B
FY202229 Apr 202227.6819.80140.09B5.06B
FY202130 Apr 202148.5123.12176.07B3.63B
FY202030 Apr 202027.2422.42130.89B4.81B
FY201926 Apr 201925.2918.06117.61B4.65B
FY201827 Apr 201835.6315.80110.29B3.10B
FY201728 Apr 201728.4717.57114.57B4.02B
FY201629 Apr 201631.5317.29111.57B3.54B
FY201530 Apr 201530.4917.0581.56B2.68B
FY201425 Apr 201419.0313.5058.33B3.07B
FY201330 Apr 201313.7212.9047.58B3.47B
FY201230 Apr 201211.1310.7940.26B3.62B
FY201130 Apr 201114.5312.4644.98B3.10B
FY201030 Apr 201015.6013.6148.33B3.10B
FY200930 Apr 200916.5510.7035.90B2.17B
FY200830 Apr 200824.6718.1655.04B2.23B
FY200730 Apr 200721.7223.1160.85B2.80B
FY200630 Apr 200623.6222.4960.16B2.55B
FY200530 Apr 200535.3726.2363.81B1.80B
FY200430 Apr 200431.2629.1761.24B1.96B
FY200330 Apr 200336.3331.6258.12B1.60B
FY200230 Apr 200255.0334.3854.15B984.00M
FY200130 Apr 200151.2940.1853.65B1.05B
FY200030 Apr 200056.8351.9962.42B1.10B
FY199930 Apr 199990.3943.8742.34B468.40M
FY199830 Apr 199851.2639.5530.48B594.60M
FY199730 Apr 199737.3529.8419.79B530.00M
FY199630 Apr 199628.87—12.64B437.80M
FY199530 Apr 199528.76—8.45B294.00M
FY199430 Apr 199418.57—4.32B232.40M
FY199330 Apr 199318.15—3.84B211.60M
FY199230 Apr 199224.06—3.89B161.50M
FY199130 Apr 199124.86—3.32B133.40M
FY199030 Apr 199016.58—1.80B108.70M
FY198930 Apr 198913.36—1.30B97.40M
FY198830 Apr 198811.90—1.03B86.50M
FY198730 Apr 198715.44—1.14B73.80M
FY198630 Apr 198616.83—898.90M53.40M

Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters. A forecast year's P/E is today's price over the analysts' EPS estimate for that year.

See also:Market cap,P/S ratio,Dividend yield,ROE (return on equity),Debt to equity,Current ratio,All ratios

Common questions about Medtronic's P/E ratio

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.